Capstone Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $3.29M | Sell |
96,481
-6,990
| -7% | -$238K | 0.09% | 261 |
|
|
2017
Q1 | $3.22M | Buy |
103,471
+6,660
| +7% | +$207K | 0.09% | 262 |
|
|
2016
Q4 | $2.65M | Buy |
96,811
+430
| +0.4% | +$11.7K | 0.08% | 309 |
|
|
2016
Q3 | $3.17M | Sell |
96,381
-60
| -0.1% | -$1.97K | 0.09% | 268 |
|
|
2016
Q2 | $2.91M | Buy |
96,441
+5,490
| +6% | +$166K | 0.09% | 276 |
|
|
2016
Q1 | $2.56M | Sell |
90,951
-1,375
| -1% | -$38.7K | 0.07% | 324 |
|
|
2015
Q4 | $3.13M | Buy |
92,326
+4,048
| +5% | +$137K | 0.09% | 279 |
|
|
2015
Q3 | $2.81M | Buy |
88,278
+2,130
| +2% | +$67.8K | 0.09% | 289 |
|
|
2015
Q2 | $2.74M | Buy |
86,148
+140
| +0.2% | +$4.46K | 0.08% | 310 |
|
|
2015
Q1 | $2.94M | Buy |
86,008
+14,620
| +20% | +$500K | 0.08% | 294 |
|
|
2014
Q4 | $2.51M | Buy |
71,388
+13,272
| +23% | +$467K | 0.07% | 313 |
|
|
2014
Q3 | $2.08M | Buy |
58,116
+200
| +0.3% | +$7.14K | 0.07% | 326 |
|
|
2014
Q2 | $2.15M | Sell |
57,916
-280
| -0.5% | -$10.4K | 0.07% | 324 |
|
|
2014
Q1 | $1.89M | Buy |
58,196
+720
| +1% | +$23.4K | 0.06% | 377 |
|
|
2013
Q4 | $1.71M | Buy |
57,476
+5,320
| +10% | +$158K | 0.05% | 419 |
|
|
2013
Q3 | $1.35M | Sell |
52,156
-18,856
| -27% | -$490K | 0.03% | 613 |
|
|
2013
Q2 | $1.68M | Buy |
+71,012
| New | +$1.68M | 0.04% | 480 |
|